Effect of 1400W on blocking lipopolysaccharide-induced microglial toxicity to preoligodendrocytes

Ya-Fang He1, Hui-Jin Chen, Long-Huan Qian

  • 1Shanghai Institute for Pediatric Research, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

Abstract

Insights

N-[3-(aminomethyl) benzyl] acetamidine (1400W) effectively reduces lipopolysaccharide-induced microglial toxicity to preoligodendrocytes by inhibiting inducible nitric oxide synthase (iNOS). This inhibition significantly lowers toxicity markers and increases preoligodendrocyte survival, offering a potential therapeutic strategy for conditions like periventricular leukomalacia.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Immunology

Background:

  • Maternal-fetal infection/inflammation is a suspected mechanism in periventricular leukomalacia (PVL) pathogenesis.
  • Microglial (MG) activation may lead to preoligodendroglial (preOL) damage.
  • N-[3-(aminomethyl) benzyl] acetamidine (1400W), a selective inducible nitric oxide synthase (iNOS) inhibitor, was investigated for its effect on lipopolysaccharide (LPS)-induced microglial toxicity to preOLs.

Purpose of the Study:

  • To explore the efficacy of 1400W in blocking LPS-induced microglial toxicity to preOLs.
  • To investigate the role of iNOS inhibition in mitigating neuroinflammation-related preOL damage.

Main Methods:

  • Co-culture of Sprague-Dawley neonatal rat microglias (MGs) and preoligodendrocytes (preOLs).
  • Groups included: co-culture control, co-culture LPS-induced, and co-culture LPS + 1400W.
  • Measurements: nitric oxide (NO), peroxynitrite (ONOO-), iNOS levels, and preOL apoptosis rate via flow cytometry.

Main Results:

  • LPS significantly increased NO, ONOO-, iNOS levels, and preOL apoptosis compared to controls (P<0.01).
  • Treatment with 10 micromol/L 1400W significantly reduced NO, ONOO-, and iNOS levels (P<0.01).
  • 1400W treatment also significantly decreased preOL apoptosis rate compared to the LPS-only group (P<0.01).

Conclusions:

  • 1400W effectively blocks LPS-induced microglial toxicity to preOLs by specifically inhibiting iNOS.
  • This inhibition leads to reduced toxicity markers and increased preOL survival.
  • The findings suggest 1400W as a potential therapeutic agent for PVL and related conditions.

Related Concept Videos